Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

CYTOKINETICS INC Director's Dealing 2010

Jan 5, 2010

30870_dirs_2010-01-05_21dfd9ca-7af1-4a74-ae59-dfb858280b61.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: CYTOKINETICS INC (CYTK)
CIK: 0001061983
Period of Report: 2010-01-04

Reporting Person: SPUDICH JAMES A (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-01-04 Non-Qualified Stock Option (right to buy) $3.11 A 16077 Acquired 2020-01-04 Common Stock (16077) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 180600 Direct

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Non-Qualified Stock Option (right to buy) $1.2 2012-07-10 Common Stock (10000) 10000 Direct
Non-Qualified Stock Option (right to buy) $1.85 2019-05-21 Common Stock (15000) 15000 Direct
Non-Qualified Stock Option (right to buy) $2.85 2019-01-02 Common Stock (17543) 17543 Direct
Non-Qualified Stock Option (right to buy) $3.73 2018-07-01 Common Stock (6702) 6702 Direct
Non-Qualified Stock Option (right to buy) $3.83 2018-05-22 Common Stock (15000) 15000 Direct
Non-Qualified Stock Option (right to buy) $5.55 2015-05-19 Common Stock (7500) 7500 Direct
Non-Qualified Stock Option (right to buy) $6.55 2017-05-24 Common Stock (10000) 10000 Direct
Non-Qualified Stock Option (right to buy) $7.29 2016-05-25 Common Stock (7500) 7500 Direct

Footnotes

F1: This option shall vest and become exercisable as to 16,077 shares divided into equal monthly installments such that the option shall be 100% vested on January 4, 2011.

F2: This option was issued to the reporting person pursuant to the Cytokinetics 2004 Equity Incentive Plan in lieu of annual retainer of $20,000.

F3: This option is immediately exercisable upon grant and shall vest as to 417 shares on 06/01/02 and the balance of 9,583 divided into equal monthly installments thereafter such that the option shall be 100% vested on 05/01/04.

F4: This option shall vest and become exercisable as to 15,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 21, 2010.

F5: This option shall vest and become exercisable as to 17,543 shares divided into equal monthly installments such that the option shall be 100% vested on January 2, 2010.

F6: This option shall vest and become exercisable as to 6,702 shares divided into equal monthly installments such that the option shall be 100% vested on January 1, 2009.

F7: This option shall vest and become exercisable as to 15,000 shares divided into equal monthly installments such that the option shall be 100% vested on May 22, 2009.